Quantcast
Last updated on April 21, 2014 at 8:40 EDT

Latest emphysema Stories

2012-09-04 06:28:09

VIENNA, Sept. 4, 2012 /PRNewswire/ -- Grifols, a global healthcare company that specializes in the production of biological medicines derived from human plasma, announced today the recipients of the 2012 European Alpha(1)-Antitrypsin Laurell's Training Awards (eALTA). The annual awards, sponsored by Grifols, provide two fellowships of EUR50,000 to young investigators whose research contributes to the understanding and treatment of alpha(1)-antitrypsin deficiency (AAT deficiency). AAT...

2012-09-03 02:21:53

VIENNA, Sept. 3, 2012 /PRNewswire/ -- VIDA Diagnostics, a leading developer of quantitative imaging analysis software for the diagnosis and treatment planning of major pulmonary disease, announced today the release and commercial availability of Apollo® 1.2, here at the European Respiratory Society (ERS) meeting in Vienna, Austria. Apollo 1.2 showcases improved workflow and dataflow functionality streamlining VIDA's software as a service model, new interactive procedure planning features...

2012-07-30 02:25:26

MOUNTAIN VIEW, Calif., July 30, 2012 /PRNewswire/ -- PneumRx, Inc. (www.pneumrx.com), a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil (RePneu LVRC) in France. The Ministry of Health agreed to fund the study under the soutien aux techniques innovantes couteuses (STIC) program, which provides government funding for innovative medical technologies that have...

2012-07-25 09:33:05

In addition to the well-known risk factor of smoking, chronic obstructive pulmonary disease (COPD) increases lung cancer risk. A University of Colorado Cancer Center study published in the journal Cancer Prevention Research details one novel mechanism of this risk: long-term oxygen depletion stimulates signals that promote tumor growth. In addition, this early study — performed in animal models — shows that tumors fueled by these COPD-induced signals may be especially...

2012-07-17 06:27:08

RESEARCH TRIANGLE PARK, N.C., July 17, 2012 /PRNewswire/ -- Grifols, a global healthcare company based in Barcelona, Spain, today announced plans to initiate a safety trial of a novel, inhaled formulation of alpha1-proteinase inhibitor [Human] later this year. In April, the U.S. Food and Drug Administration (FDA) granted orphan drug designation for Grifols' inhaled alpha1 formulation as a treatment for cystic fibrosis, an inherited disease that can cause life-threatening lung infections....

2012-05-29 23:00:54

Medical researchers need participants for studies in Salt Lake City that are exploring ways to treat heart disease, diabetes, gout, high blood pressure, emphysema and other afflictions. SALT LAKE CITY (PRWEB) May 29, 2012 A new website launched this month by Salt Lake City-based Optimum Clinical Research offers new ways for those suffering from diabetes, heart disease, high blood pressure and other health conditions to learn about medical studies under way in Utah. Study participants are...

2012-05-23 18:40:51

A tiny, resilient metal wire designed to gather and compress diseased lung tissue may offer relief to patients with severe heterogeneous emphysema, a subtype of the disease that involves specific, usually isolated areas of the lungs, according to the results of a multicenter international trial conducted in the Netherlands, Germany and France. The wire, called a lung volume reduction coil (LVRC), can be easily implanted and is designed to take the place of more invasive procedures used to...

2012-05-23 06:26:20

SAN FRANCISCO, May 23, 2012 /PRNewswire/ -- Advanced emphysema patients who underwent minimally invasive InterVapor(TM) (bronchoscopic thermal vapor ablation) experienced sustained improved lung function and quality of life outcomes one year after undergoing treatment, according to new data presented today at the meeting of the American Thoracic Society (ATS) in San Francisco, CA. The InterVapor procedure, pioneered by U.S.-based Uptake Medical, involves catheter-based application of precise...

2012-05-21 02:25:01

MOUNTAIN VIEW, Calif., May 21, 2012 /PRNewswire/ -- PneumRx, Inc. (www.pneumrx.com), a medical device company dedicated to bringing innovation and improvements to the treatment of lung disease, today announced that it has expanded its intellectual property portfolio by acquiring key patents and domain names from Broncus Technologies. (Logo: http://photos.prnewswire.com/prnh/20120514/SF06703LOGO) As a result of the acquisition, PneumRx now owns numerous domain names, including emphysema.com,...

2012-05-15 02:28:50

MOUNTAIN VIEW, Calif., May 15, 2012 /PRNewswire/ -- PneumRx, Inc. (www.pneumrx.com), a medical device company dedicated to bringing innovation and improvements to the treatment of lung disease, today announced that it has received FDA approval to commence a 30-site pivotal clinical trial to support a PMA application for the RePneu LVRC System. (Logo: http://photos.prnewswire.com/prnh/20120514/SF06703LOGO) The RePneu LVRC System is a minimally invasive device intended to improve...


Latest emphysema Reference Libraries

Lung
2013-01-01 15:53:59

The lung is a vital organ that is a part of the respiratory system. Generally a person has two lungs; however, the body can function with only one. The lung’s main function is to move oxygen and carbon dioxide into and out of the bloodstream through gas exchange. The lungs are located lateral to the heart in the thoracic cavity. Each lung has a tip called the apex, which is superior in the body. The bases of the lungs rest on the diaphragm. They appear to be spongy due to their bundles of...

More Articles (1 articles) »